```html

Xanthopsia‑Induced Visual Halo

What is Xanthopsia‑induced visual halo?

Xanthopsia is a visual disturbance in which objects appear yellow‑tinted. When this yellow hue is accompanied by a halo—a luminous ring or “glow” around lights—it is described as xanthopsia‑induced visual halo. The halo may be seen around headlights, streetlamps, computer screens, or even everyday objects such as a coffee cup.

The phenomenon results from altered retinal or neural processing of light wavelengths, most often in the yellow‑to‑green spectrum (≈570–590 nm). While occasional, mild halos are normal (e.g., after bright sunlight), persistent or worsening halos can signal an underlying ocular or systemic problem.

Understanding the cause is crucial because the same symptom can appear in benign situations (like using certain medications) or in potentially sight‑threatening diseases (such as angle‑closure glaucoma).

Common Causes

Below are the most frequent conditions and factors that can produce a yellow‑tinted halo vision:

• Medications: Digoxin, quinine, anticholinergics, some antibiotics (e.g., chloroquine) and certain anti‑psychotics can alter cone photoreceptor response.
• Ocular surgery: Post‑cataract or refractive surgery may create transient halos due to corneal edema or intra‑ocular lens (IOL) edge effects.
• Glaucoma: Particularly acute angle‑closure glaucoma, where elevated intra‑ocular pressure distorts the cornea and creates colorful halos.
• Cataracts: Early nuclear sclerosis scatters short‑wavelength light, leaving a predominance of yellow‑green halos.
• Corneal edema: Swollen corneal cells act as a “diffusing” lens, producing halos of any hue; with yellow‑biased illumination the halo appears xanthopsic.
• Retinal disorders: Central serous chorioretinopathy or macular edema can shift color perception.
• Systemic diseases: Liver disease (jaundice) and severe anemia may change the spectral composition of the light reaching the retina.
• Neurological conditions: Migraine aura, especially with scintillating scotomas, sometimes includes yellow‑colored halos.
• Exposure to bright or filtered light: Wearing yellow‑tinted glasses, welding goggles, or prolonged use of LED screens in dark rooms can produce adaptation‑related halos.
• Vitamin A toxicity or deficiency: Both extremes can disrupt cone function, leading to abnormal color halos.

Associated Symptoms

Visual halos rarely occur in isolation. The following symptoms frequently accompany xanthopsia‑induced halos, helping clinicians narrow the cause:

• Glare or reduced contrast sensitivity – difficulty seeing edges, especially at night.
• Color distortion – objects may look more yellow, green, or have a washed‑out appearance.
• Eye pain or pressure – common in acute glaucoma or corneal edema.
• Headache or nausea – typical of migraine aura or raised intra‑ocular pressure.
• Photophobia – heightened sensitivity to light.
• Blurred or double vision – often linked to corneal swelling or early cataract formation.
• Floaters or flashing lights – may suggest retinal involvement.
• Systemic signs – jaundice, fatigue, or medication side‑effects.

When to See a Doctor

Most cases are not an emergency, but prompt evaluation is essential when any of the following occur:

• Halos appear suddenly or worsen within hours.
• You experience eye pain, pressure, or a feeling of fullness.
• Vision becomes blurry, double, or you lose part of your visual field.
• Headache is severe, especially if accompanied by nausea or vomiting.
• You have a known risk factor for glaucoma (family history, diabetes, high myopia).
• You have recently started or changed dose of a medication known to affect vision.
• Halos persist despite resting eyes, avoiding bright lights, or wearing appropriate glasses.

If any of these red flags are present, schedule an eye‑care appointment within 24‑48 hours or seek urgent care.

Diagnosis

Evaluation usually begins with a comprehensive eye exam performed by an optometrist or ophthalmologist.

History Taking

• Onset, duration, and pattern of halos.
• Medication list (including over‑the‑counter and herbal supplements).
• Past ocular surgeries, trauma, or chronic eye disease.
• Systemic illnesses (liver disease, diabetes, hypertension).

Physical Examination

• Visual acuity test – to quantify any loss.
• Slit‑lamp biomicroscopy – assesses cornea, anterior chamber, and lens for edema or cataract.
• Intra‑ocular pressure (IOP) measurement – using Goldmann applanation tonometry.
• Gonioscopy – evaluates the angle of drainage in glaucoma suspicion.
• Fundus examination – checks retina and optic nerve for edema, hemorrhage, or macular changes.

Specialized Tests

• Optical Coherence Tomography (OCT) – high‑resolution imaging of retinal layers.
• Corneal topography – maps corneal curvature, useful after refractive surgery.
• Visual field testing – detects peripheral loss typical of glaucoma.
• Blood work – liver function tests, complete blood count, and drug levels when systemic causes are suspected.

Treatment Options

Treatment is directed at the underlying cause. Below are the most common therapeutic pathways.

Medication‑related Halos

• Adjust dose or discontinue the offending drug under physician guidance.
• Consider alternative agents (e.g., switching from digoxin to a beta‑blocker for heart failure).

Glaucoma

• Acute angle‑closure: Immediate lowering of IOP with topical beta‑blockers, alpha‑agonists, carbonic anhydrase inhibitors, and oral acetazolamide. Definitive treatment often requires laser peripheral iridotomy.
• Chronic open‑angle: Daily topical prostaglandin analogs or combination drops; laser trabeculoplasty if medication alone is insufficient.

Cataract‑related Halos

• Early cataracts may be monitored; visual disturbances that affect daily activities can be improved with modern low‑energy phacoemulsification and premium IOLs.

Corneal Edema

• Hypertonic saline eye drops or ointment.
• Topical steroids (short‑term) to reduce inflammation.
• Address underlying cause—e.g., stopping contact lens wear, treating endothelial dystrophy.

Post‑Surgical Halos

• Prescription of anti‑glare glasses (yellow‑tinted lenses) during the healing phase.
• Re‑evaluation of IOL positioning; in rare cases, IOL exchange may be needed.

Systemic Causes

• Management of liver disease, anemia, or vitamin imbalances per internal‑medicine guidelines.
• Referral to a hepatologist, hematologist, or nutritionist as appropriate.

Supportive & Home Measures

• Use of anti‑glare eyewear (polarized lenses) in bright environments.
• Ensuring adequate ambient lighting; avoid stark contrast between dark rooms and bright screens.
• Regular breaks during prolonged screen use (20‑20‑20 rule).
• Stay hydrated and maintain a balanced diet rich in lutein and zeaxanthin for retinal health.

Prevention Tips

While not all causes are preventable, many strategies lower the risk of developing xanthopsia‑induced visual halos.

• Medication review: Have a pharmacist or physician evaluate all prescriptions for visual side‑effects annually.
• Eye‑health check‑ups: Adults ≥40 years should have a comprehensive eye exam every 1–2 years; high‑risk individuals (family history of glaucoma, diabetes) may need yearly exams.
• Protect your eyes: Wear sunglasses with UV protection; avoid staring directly at bright headlights or welding arcs.
• Manage systemic disease: Keep blood glucose, blood pressure, and cholesterol under control to reduce cataract and glaucoma risk.
• Healthy lifestyle: Quit smoking, limit alcohol, and eat a diet high in omega‑3 fatty acids and antioxidants.
• Screen hygiene: Use blue‑light filters, keep screen brightness moderate, and follow the 20‑20‑20 rule (every 20 minutes look at something 20 feet away for 20 seconds).
• Regular sleep patterns: Adequate rest reduces ocular strain and migraine frequency.

Emergency Warning Signs

Key Takeaways

• Xanthopsia‑induced visual halo is a yellow‑tinted glow around lights that can stem from medication, eye disease, systemic illness, or environmental factors.
• Because the symptom overlaps with sight‑threatening conditions like acute glaucoma, timely evaluation by an eye‑care professional is essential.
• Diagnosis involves a detailed history, slit‑lamp exam, intra‑ocular pressure measurement, and often imaging such as OCT.
• Treatment targets the underlying cause—adjusting medications, lowering eye pressure, addressing corneal edema, or cataract surgery when indicated.
• Prevention focuses on regular eye exams, medication management, systemic disease control, and protective visual habits.

For further reading, consult reputable sources such as the Mayo Clinic, CDC, NIH, WHO, and the Cleveland Clinic.

```